Fig. S2
. Mouse GBM derived cells are insensitive to most standard of care chemotherapeutic agents. Primary GBM cells were treated with Temozolomide, doxorubicin, and paclitaxel for 72h and subjected to XTT assays as described in Materials and Methods. Curves show the percentage viability of chemotherapy-treated cells (A), MBR614-2; (B), MBR525-1; (C), MBR61; (D), MBR628) compared with the vehicle treated control cells. Each agent testing was repeated at least in 3 times in three independent experiments. Each dose treatment was done in triplicate, and bars represent s.d. 
